The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
Open accessThe DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 4×
“Despite the importance of T lymphocytes in immunosurveillance and control of early tumor growth, chronic tumor cell secretion of cytokines and other soluble factors subsequently (1) induce, expand, and recruit Treg cells to tumor sites, (2) stimulate mature and immature DCs to provide antigenic stimulation and immunos…”
BackgroundInfluentialImmunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110
Somatic generation of antibody diversity
Tonegawa, S. (1983) · Nature · doi:10.1038/302575a0 · Cited by 4,005
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 3×
“Despite the importance of T lymphocytes in immunosurveillance and control of early tumor growth, chronic tumor cell secretion of cytokines and other soluble factors subsequently (1) induce, expand, and recruit Treg cells to tumor sites, (2) stimulate mature and immature DCs to provide antigenic stimulation and immunos…”
BackgroundEvolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Somatic generation of antibody diversity.
Matthyssens, G., Hozumi, N., & Tonegawa, S. (1976) · PubMed · Cited by 3,244
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Shimizu, J., Yamazaki, S., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5211 · Cited by 1,491
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Macrophage Polarization Comes of Age
Mantovani, Sica, & Locati, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.001 · Cited by 1,259
Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., & Nakayama, E. (1999) · PubMed · Cited by 1,255
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
Gao, Q., Qiu, S.-J., Fan, J., Zhou, J., Wang, X.-Y., Xiao, Y.-S., Xu, Y., Li, Y.-W., & Tang, Z.-Y. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,110
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,089
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 1,010
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946
The interface between innate and adaptive immunity
Hoebe, K., Janssen, E., & Beutler, B. (2004) · Nature Immunology · doi:10.1038/ni1004-971 · Cited by 916
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Liesenborghs, L., Koch, M., De Mol, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.038 · Cited by 779
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2360 · Cited by 758
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Selecting and maintaining a diverse T-cell repertoire
Goldrath, A. W., & Bevan, M. J. (1999) · Nature · doi:10.1038/35005508 · Cited by 714
NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., & Berzofsky, J. A. (2000) · Nature Immunology · doi:10.1038/82771 · Cited by 699
Woo, E. Y., Yeh, H., Chu, C. S., Schlienger, K., Carroll, R. G., Riley, J. L., Kaiser, L. R., & June, C. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4272 · Cited by 696
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.-H., Yao, J., Blanchard, D., Bais, C., Peale, F. V., van Bruggen, N., et al. (2007) · Nature · doi:10.1038/nature06348 · Cited by 644
Mantovani, A. (2009) · Nature · doi:10.1038/457036b · Cited by 643
Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells
Gilliet, M., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011603 · Cited by 638
Bunt, S. K., Yang, L., Sinha, P., Clements, V. K., Leips, J., & Ostrand-Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2354 · Cited by 633
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Self-citationInflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells
Spaeth, E., Klopp, A., Dembinski, J., Andreeff, M., & Marini, F. (2008) · Gene Therapy · doi:10.1038/gt.2008.39 · Cited by 579
Close encounters of different kinds: Dendritic cells and NK cells take centre stage
Degli-Esposti, M. A., & Smyth, M. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1549 · Cited by 554
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Sprent, J., & Surh, C. D. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100101.151926 · Cited by 534
Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Swigart, L. B., & Evan, G. I. (2007) · Nature Medicine · doi:10.1038/nm1649 · Cited by 507
Sharma, S., Yang, S.-C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., Huang, M., Batra, R. K., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0141 · Cited by 506
Venneri, M. A., Palma, M. D., Ponzoni, M., Pucci, F., Scielzo, C., Zonari, E., Mazzieri, R., Doglioni, C., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2006-10-053504 · Cited by 505
Hiraoka, K., Miyamoto, M., Cho, Y., Suzuoki, M., Oshikiri, T., Nakakubo, Y., Itoh, T., Ohbuchi, T., Kondo, S., & Katoh, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602934 · Cited by 481
Immune surveillance: a balance between protumor and antitumor immunity
Ostrand-Rosenberg, S. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.007 · Cited by 480
Villegas, F. R., Coca, S., Villarrubia, V. G., Jiménez, R., Chillón, M. J., Jareño, J., Zuil, M., & Callol, L. (2002) · Lung Cancer · doi:10.1016/s0169-5002(01)00292-6 · Cited by 467
Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., & Sica, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1867 · Cited by 455
Jarnicki, A. G., Lysaght, J., Todryk, S., & Mills, K. H. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.896 · Cited by 445
Ma, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-112 · Cited by 437
Petersen, R. P., Campa, M. J., Sperlazza, J., Conlon, D., Joshi, M., Harpole, D. H., & Patz, E. F. (2006) · Cancer · doi:10.1002/cncr.22282 · Cited by 433
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer
Butts, C., Murray, N., Maksymiuk, A., Goss, G., Marshall, E., Soulières, D., Cormier, Y., Ellis, P., Price, A., Sawhney, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.011 · Cited by 428
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Dendritic cell maturation by innate lymphocytes
Münz, C., Steinman, R. M., & Fujii, S.-I. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050810 · Cited by 393
Kawai, O., Ishii, G., Kubota, K., Murata, Y., Naito, Y., Mizuno, T., Aokage, K., Saijo, N., Nishiwaki, Y., Gemma, A., et al. (2008) · Cancer · doi:10.1002/cncr.23712 · Cited by 384
Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., & Ferlazzo, G. (2008) · Cancer · doi:10.1002/cncr.23239 · Cited by 379
Welsh, T. J., Green, R. H., Richardson, D., Waller, D. A., O'Byrne, K. J., & Bradding, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4910 · Cited by 369
CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer
Kiniwa, Y., Miyahara, Y., Wang, H. Y., Peng, W., Peng, G., Wheeler, T. M., Thompson, T. C., Old, L. J., & Wang, R.-F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0842 · Cited by 352
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Carosella, E. D., Favier, B., Rouas-Freiss, N., Moreau, P., & LeMaoult, J. (2008) · Blood · doi:10.1182/blood-2007-12-127662 · Cited by 348
Derangement of immune responses by myeloid suppressor cells
Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., & Bronte, V. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0443-2 · Cited by 335
Immune escape as a fundamental trait of cancer: focus on IDO
Prendergast, G. C. (2008) · Oncogene · doi:10.1038/onc.2008.35 · Cited by 325
Immune suppression and skin cancer development: regulation by NKT cells
Moodycliffe, A. M., Nghiem, D., Clydesdale, G., & Ullrich, S. E. (2000) · Nature Immunology · doi:10.1038/82782 · Cited by 320
Inflammatory cell infiltration of tumors: Jekyll or Hyde
Talmadge, J. E., Donkor, M., & Scholar, E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9072-0 · Cited by 313
Hamerman, J. A., Ogasawara, K., & Lanier, L. L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.11.001 · Cited by 304
Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A., & Bradding, P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00065708 · Cited by 296
Esposito, I., Menicagli, M., Funel, N., Bergmann, F., Boggi, U., Mosca, F., Bevilacqua, G., & Campani, D. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014498 · Cited by 257
Wakabayashi, O., Yamazaki, K., Oizumi, S., Hommura, F., Kinoshita, I., Ogura, S., Dosaka‐Akita, H., & Nishimura, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01392.x · Cited by 252
Shimizu, K., Nakata, M., Hirami, Y., Yukawa, T., Maeda, A., & Tanemoto, K. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d60fd7 · Cited by 244
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future
Vivier, E., & Anfossi, N. (2004) · Nature Reviews Immunology · doi:10.1038/nri1306 · Cited by 236
Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma
Takanami, I., Takeuchi, K., & Naruke, M. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2686::aid-cncr6>3.0.co;2-6 · Cited by 231
Tschernig, T., & Pabst, R. (2000) · Pathobiology · doi:10.1159/000028109 · Cited by 228
NKT cells and tumor immunity—a double-edged sword
Smyth, M. J., & Godfrey, D. I. (2000) · Nature Immunology · doi:10.1038/82698 · Cited by 209
Ruckdeschel, J. C., Codish, S. D., Stranahan, A., & McKneally, M. F. (1972) · New England Journal of Medicine · doi:10.1056/nejm197211162872004 · Cited by 203
The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma
Takanami, I., Takeuchi, K., & Giga, M. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.113026 · Cited by 174
L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer
Sangha, R., & Butts, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0213 · Cited by 173
Dumitriu, I. E., Dunbar, D. R., Howie, S. E., Sethi, T., & Gregory, C. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0712671 · Cited by 171
McHeyzer‐Williams, M. G. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00046-3 · Cited by 168
Kataki, A., Scheid, P., Piet, M., Marie, B., Martinet, N., Martinet, Y., & Vignaud, J.-M. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.128317 · Cited by 166
Natural killer lymphocytes: biology, development, and function
Baxevanis, C. N., Papamichail, M., Perez, S. A., & Gritzapis, A. D. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0478-4 · Cited by 165
NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis
Terabe, M., & Berzofsky, J. A. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.05.008 · Cited by 162
Natural killer cells: from CD3−NKp46+ to post-genomics meta-analyses
Walzer, T., Jaeger, S., Chaix, J., & Vivier, E. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.004 · Cited by 161
Dai, F., Liu, L., Che, G., Yu, N., Pu, Q., Zhang, S., Ma, J., Ma, L., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-220 · Cited by 153
Vansteenkiste, J., Zielinski, M., Linder, A., Dahabre, J., Esteban, E., Malinowski, W., Jassem, J., Passlick, B., Lehmann, F. F., & Brichard, V. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.7554 · Cited by 151
Palma, M. D., Venneri, M. A., Galli, R., Sergi, L., Politi, L., Sampaolesi, M., & Naldini, L. (2005) · Lirias · doi:10.1016/j.ccr.2005.08.0052 · Cited by 151
Bronchus‐associated lymphoid tissue (BALT) in human fetal and infant lung
Gould, S. J., & Isaacson, P. G. (1993) · The Journal of Pathology · doi:10.1002/path.1711690209 · Cited by 138
Immune cell infiltrates and prognosis in primary carcinoma of the lung
Johnson, S. K., Kerr, K. M., Chapman, A. D., Kennedy, M. M., King, G., Cockburn, J. S., & Jeffrey, R. R. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00095-1 · Cited by 134
Lodie, T. A., Blickarz, C. E., Devarakonda, T. J., He, C., Dash, A. B., Clarke, J., Gleneck, K., Shihabuddin, L., & Tubo, R. (2002) · Tissue Engineering · doi:10.1089/10763270260424105 · Cited by 133
Mast cell contribution to angiogenesis related to tumour progression
Ribatti, D., Crivellato, E., Roccaro, A. M., Ria, R., & Vacca, A. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02104.x · Cited by 132
Hiraoka, K., Zenmyo, M., Watari, K., Iguchi, H., Fotovati, A., Kimura, Y. N., Hosoi, F., Shoda, T., Nagata, K., Osada, H., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00880.x · Cited by 132
Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis
Yano, H., Kinuta, M., Tateishi, H., Nakano, Y., Matsui, S., Monden, T., Okamura, J., Sakai, M., & Okamoto, S. (1999) · Gastric Cancer · doi:10.1007/s101200050017 · Cited by 129
Inoshima, N., Nakanishi, Y., Minami, T., Izumi, M., Takayama, K., Yoshino, I., & Hara, N. (2002) · PubMed · Cited by 114
Dendritic cell infiltration and prognosis of human hepatocellular carcinoma
Cai, X., Gao, Q., Qiu, S., Ye, S., Wu, Z.-Q., Fan, J., & Tang, Z. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0075-y · Cited by 106
Al-Shibli, K. I., Al‐Saad, S., Dønnem, T., Persson, M., Bremnes, R. M., & Busund, L. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03379.x · Cited by 103
Self-citationEsendağlı, G., Bruderek, K., Goldmann, T., Busche, A., Branscheid, D., Vollmer, E., & Brandau, S. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.07.022 · Cited by 101
CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer
Wang, R.-F. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.276 · Cited by 100
Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier, M. P., Edwardes, M., Michel, R. P., Halwani, F., & Morin, J. E. (2001) · Europe PMC (PubMed Central) · Cited by 88
The interplay between innate and adaptive immunity regulates cancer development
de Visser, K. E., & Coussens, L. M. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0702-5 · Cited by 83
A Central Role for Foxp3+ Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis
Granville, C. A., Memmott, R. M., Balogh, A., Mariotti, J., Kawabata, S., Han, W., LoPiccolo, J., Foley, J., Liewehr, D. J., Steinberg, S. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005061 · Cited by 80
The Plasticity of γδ T Cells: Innate Immunity, Antigen Presentation and New Immunotherapy
Casetti, R., & Martino, A. (2008) · Cellular and Molecular Immunology · doi:10.1038/cmi.2008.20 · Cited by 79
Li, Q., Guo, Z., Xu, X., Xia, S., & Cao, X. (2008) · European Journal of Immunology · doi:10.1002/eji.200838542 · Cited by 76
Schütt, P., Schütt, B., Switala, M., Bauer, S., Stamatis, G., Opalka, B., Eberhardt, W., Schüler, M., Horn, P. A., & Rebmann, V. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.02.015 · Cited by 69
Lin, A., Zhu, C., Chen, H. ‐., Chen, B. ‐., Zhang, X., Zhang, J. ‐., Wang, Q., Zhou, W., Hu, W., Yang, H., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00858.x · Cited by 65
CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer
Coventry, B. J., & Morton, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601114 · Cited by 62
Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma
Tomita, M., Matsuzaki, Y., & Onitsuka, T. (1999) · Lung Cancer · doi:10.1016/s0169-5002(99)00076-8 · Cited by 56
Partial regression in primary carcinoma of the lung: does it occur?
Kerr, K. M., Johnson, S. K., King, G., Kennedy, M. M., Weir, J., & Jeffrey, R. (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00453.x · Cited by 55
Mami‐Chouaib, F., Echchakir, H., Dorothée, G., Vergnon, I., & Chouaïb, S. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18810.x · Cited by 55
Lee, T., Horner, R. D., Silverman, J. F., Chen, Y.-H., Jenny, C., & Scarantino, C. W. (1989) · Cancer · doi:10.1002/1097-0142(19890115)63:2<309::aid-cncr2820630218>3.0.co;2-n · Cited by 52
The development of immunotherapies for non-small cell lung cancer
Salgaller, M. L. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.3.265 · Cited by 49
Dundar, E., Oner, U., Peker, B. C., Metintas, M., Isiksoy, S., & Ak, G. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600112 · Cited by 48
Ishibashi, Y., Tanaka, S., Tajima, K., Yoshida, T., & Kuwano, H. (2006) · Oncology Reports · doi:10.3892/or.15.5.1315 · Cited by 43
Törmänen‐Näpänkangas, U., Soini, Y., & Pääkkö, P. K. (2001) · Apmis · doi:10.1111/j.1600-0463.2001.907806.x · Cited by 21
Immunotherapy in Non–Small-Cell Lung Carcinoma: From Inflammation to Vaccination
van den Heuvel, M. M., Burgers, S. A., & van Zandwijk, N. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.012 · Cited by 16
Early Clinical Trial Experience with Vaccine Therapies in Non–Small-Cell Lung Cancer
Ho, C., Ochsenbein, A. F., Gautschi, O. P., & Davies, A. M. (2008) · Clinical Lung Cancer · doi:10.3816/clc.2008.s.004 · Cited by 9
Cited by
Chaudhary, B., & Elkord, E. (2016) · Vaccines · doi:10.3390/vaccines4030028 · Cited by 511
Bremnes, R. M., Busund, L.-T., Kilvær, T. L., Andersen, S., Richardsen, E., Paulsen, E. E., Hald, S., Khanehkenari, M. R., Cooper, W. A., Kao, S. C., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.01.015 · Cited by 502
Self-citationPulmonary toxicity of carbon nanotubes and asbestos — Similarities and differences
Donaldson, K., Poland, C. A., Murphy, F. A., MacFarlane, M., Chernova, T., & Schinwald, A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.014 · Cited by 341
Th17 Cells in Cancer: The Ultimate Identity Crisis
Bailey, S. R., Nelson, M. H., Himes, R. A., Li, Z., Mehrotra, S., & Paulos, C. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00276 · Cited by 334
Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer
Donnem, T., Hald, S. M., Paulsen, E.-E., Richardsen, E., Al-Saad, S., Kilvaer, T. K., Brustugun, O. T., Helland, A., Lund-Iversen, M., Poehl, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1905 · Cited by 312
Self-citation
Metadata
- Authors
- Bremnes, R. M., Al-Shibli, K., Donnem, T., Sirera, R., Al-Saad, S., Andersen, S., Stenvold, H., Camps, C., & Busund, L.-T.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 6
- Issue
- 4
- Pages
- 824-833
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2080571923
- Cited by
- 369
- References
- 140
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.